SGO 2018

Pembrolizumab: Cost-Effective for Recurrent, MSI-H Endometrial Cancer

Pembrolizumab: Cost-Effective for Recurrent, MSI-H Endometrial Cancer

By

Per-cycle, PLD cost $2509, bevacizumab cost $7585, and pembrolizumab cost $9026.

Uterine Re-Curettage May Not Affect Required Chemotherapy Courses in GTN

Uterine Re-Curettage May Not Affect Required Chemotherapy Courses in GTN

By

After the initial year of follow-up, 2 patients in the standard arm and 1 patient in the re-curettage arm had relapsed.

Adjuvant Chemotherapy Non-Inferior to Chemoradiotherapy in Cervical Cancer

Adjuvant Chemotherapy Non-Inferior to Chemoradiotherapy in Cervical Cancer

By

There were no significant differences in patterns of recurrence in the chemotherapy vs CCRT groups.

Bevacizumab Plus Chemotherapy Prolongs PFS in Endometrial Cancer With p53 Null Status

Bevacizumab Plus Chemotherapy Prolongs PFS in Endometrial Cancer With p53 Null Status

By

p53 mutational status may be a viable strategy upon which to base the course of therapy.

One-Quarter of Patients With Gynecologic Cancer Cannot Afford Medical Care

One-Quarter of Patients With Gynecologic Cancer Cannot Afford Medical Care

By

Nearly half of patients were denied insurance coverage for a recommended treatment.

GTN: MTX With, Without Dactinomycin May Be Effective Option

GTN: MTX With, Without Dactinomycin May Be Effective Option

By

Patients in the single-course MTX+ACTD arm had a 46.81% CR rate after initial therapy.

Gynecologic Abdominal Surgery: Liposomal Bupivacaine May Reduce Opioid Use

Gynecologic Abdominal Surgery: Liposomal Bupivacaine May Reduce Opioid Use

By

Researchers randomly assigned 120 patients to receive bupivacaine HCl or liposomal bupivacaine.

Indocyanine Green Improves Sentinel Node Detection in Uterine Malignancies

Indocyanine Green Improves Sentinel Node Detection in Uterine Malignancies

By

Overall, 257 vs 527 SLNs were detected by isosulfan blue vs ICG, respectively.

Affordable Care Act Increased Percentage of Insured Patients With Gynecologic Cancers

Affordable Care Act Increased Percentage of Insured Patients With Gynecologic Cancers

By

The impact of the ACA on health insurance access among women diagnosed with a gynecologic cancer was previously unestablished.

Everolimus Plus Letrozole May Be Active in Recurrent Endometrial Carcinoma

Everolimus Plus Letrozole May Be Active in Recurrent Endometrial Carcinoma

By

Researchers randomly assigned 74 patients to receive everolimus plus letrozole daily or tamoxifen daily plus medroxyprogesterone daily on alternating weeks.

Opioid Prescription Protocol Decreases Opioid Use After Gynecologic Surgery

Opioid Prescription Protocol Decreases Opioid Use After Gynecologic Surgery

By

There were no reported changes in pain scores after surgery.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs